H. C. Morse

In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS)

N. Giese, R. Gazzinelli, H. Morse, 1994, The Journal of experimental medicine.

Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10

B. Murphy, M. Connors, N. Giese, 1994, Journal of virology.

Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains

H. Morse, J. Hartley, T. Fredrickson, 1989, Journal of virology.

Effects of exogenous, nonleukemogenic, ecotropic murine leukemia virus infections on the immune systems of adult C57BL/6 mice

N. Giese, H. Morse, K. Elkins, 1995, Journal of virology.

Abrogation of resistance to severe mousepox in C57BL/6 mice infected with LP-BM5 murine leukemia viruses

R. Buller, H. Morse, T. Fredrickson, 1987, Journal of virology.

Murine cytomegalovirus infection-induced polyclonal B cell activation is independent of CD4+ T cells and CD40.

J. H. Chen, G. Karupiah, H. Morse, 1998, Virology.